Resultado da interdisciplinaridade das especialidades oncologia e cardiologia na prevenção e tratamento da cardiotoxicidade decorrente de quimioterápicos

Abstract

Introduction: cardiovascular disease and cancer are among the top four non-communicable diseases, responsible for 36 million deaths worldwide. Concerning patients with cancer, cardiovascular disease are increasingly common, and because of that, became necessary the development of more advanced therapeutic technologies in order to increase expectations and improve the quality of life of patients with heart disease and cancer. Emphasizes the relevance of this study asking whether the sum of specialties contributes to the prevention of cardiovascular disease triggered by cardiotoxicity of chemotherapy therapies in cancer patients. This result may support the implementation of recommendations by professionals in clinical practice for the harm reduction. Objective: identify the result of interdisciplinary between cardiology and oncology in preventing cardiotoxicity in cancer patients. Methodology: this is an integrative review whose core question was: interdisciplinarity between cardiovascular and oncological team prevents heart disease in patients with cancer triggered by the cardiotoxicity of chemotherapy? The search for these studies with selected descriptors was held in the following databases: SciELO, LILACS, MEDLINE, COCHRANE LIBRARY and IBECS. The access to those databases was through the Virtual Health Library. After evaluation of the selection criteria, were ranked four review articles for the sample. Results and Conclusions: cardiotoxicity triggered by chemotherapy is of great relevance in the development of heart disease, and demonstrably, cardiotoxic effects in cancer patients were present, but few studies have demonstrated this fact and also just a few of them, showed the existence of the interdisciplinary interaction between cardio-oncology teams. This fact evidences the necessity for a more effective interdiciplinary approach between such teams, in order to prevent larger complications and improve the quality of life of these patients. The cardiovascular and oncology professionals have a key role in order to bring important results of this interdisciplinary interaction, beginning with defining and implementing strategies for prevention of heart disease by cardiotoxicity.